Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis

Adds Pharmaceutical and Business Operations Expertise with Key Relationships to Provide Growth Opportunities for Canbiola HICKSVILLE, NY, May 06, 2019

Read more

Featured Interview: CFO Stanley Teeple of Canbiola, Inc. (OTCQB: CANB)

CFO Stanley Teeple of Canbiola, Inc. ,talks in detail about revenue growth over the past year, their physician only line of CBD products, durable medical device division, and new brands.

Read more

Featured Interview: VP of Sales Andy Holtmeyer of Canbiola, Inc. (OTCQB: CANB)

Executive VP of Sales Andy Holtmeyer of Canbiola, Inc., discusses entering the medical device space, growing their clinical and retail CBD brands, and educating patients.

Read more

Canbiola is Registered and Active in the GSA’s System for Award Management (SAM) and Department of Defense (DOD)

Widens the Availability of its CBD Products Hicksville, NY – (NewMediaWire) – March 11, 2019 – Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or

Read more